Another step forward in the 20-year history of mutations in chronic lymphocytic leukemia.
作者信息
Giudice Ilaria Del, Foà Robin
机构信息
Hematology, Department of Translational and Precision Medicine, 'Sapienza' University, Rome, Italy.
Hematology, Department of Translational and Precision Medicine, 'Sapienza' University, Rome, Italy
出版信息
Haematologica. 2019 Feb;104(2):219-221. doi: 10.3324/haematol.2018.207399.
Abstract
摘要
相似文献
1
Another step forward in the 20-year history of mutations in chronic lymphocytic leukemia.
Haematologica. 2019 Feb;104(2):219-221. doi: 10.3324/haematol.2018.207399.
2
Genomic complexity and IGHV mutational status are key predictors of outcome of chronic lymphocytic leukemia patients with TP53 disruption.
Haematologica. 2014 Nov;99(11):e231-4. doi: 10.3324/haematol.2014.108365. Epub 2014 Jul 4.
3
MYD88 mutations predict unfavorable prognosis in Chronic Lymphocytic Leukemia patients with mutated IGHV gene.
Blood Cancer J. 2017 Dec 15;7(12):651. doi: 10.1038/s41408-017-0014-y.
4
Association between immunoglobulin heavy-chain variable region mutational status and isolated favorable baseline genomic aberrations in chronic lymphocytic leukemia.
Leuk Lymphoma. 2018 Jan;59(1):59-68. doi: 10.1080/10428194.2017.1323271. Epub 2017 Jun 22.
5
Mutational status of IgV(H) genes in B-cell chronic lymphocytic leukemia and prognosis: percent mutations or antigen-driven selection?
Leukemia. 2005 Aug;19(8):1490-2. doi: 10.1038/sj.leu.2403830.
6
COBLL1, LPL and ZAP70 expression defines prognostic subgroups of chronic lymphocytic leukemia patients with high accuracy and correlates with IGHV mutational status.
Leuk Lymphoma. 2017 Jan;58(1):70-79. doi: 10.1080/10428194.2016.1180690. Epub 2016 May 17.
7
The signs of negative selection in IGHV framework regions are associated with worse overall survival of chronic lymphocytic leukemia patients.
Leuk Res. 2021 Nov;110:106686. doi: 10.1016/j.leukres.2021.106686. Epub 2021 Aug 25.
8
A subset of Binet stage A CLL patients with TP53 abnormalities and mutated IGHV genes have stable disease.
Leukemia. 2009 Jan;23(1):212-4. doi: 10.1038/leu.2008.260. Epub 2008 Sep 25.
9
Reliable IGHV status assessment by next generation sequencing in routine practice for chronic lymphocytic leukemia.
Leuk Lymphoma. 2021 Nov;62(11):2800-2803. doi: 10.1080/10428194.2021.1933476. Epub 2021 Jun 1.
10
IgVH mutations in patients with chronic lymphocytic leukemia.
Haematologica. 2005 Apr;90(4):434-5.
引用本文的文献
1
Insights into genetic aberrations and signalling pathway interactions in chronic lymphocytic leukemia: from pathogenesis to treatment strategies.
Biomark Res. 2024 Dec 28;12(1):162. doi: 10.1186/s40364-024-00710-w.
2
Low Cell Bioenergetic Metabolism Characterizes Chronic Lymphocytic Leukemia Patients with Unfavorable Genetic Factors and with a Better Response to BTK Inhibition.
Curr Issues Mol Biol. 2024 May 22;46(6):5085-5099. doi: 10.3390/cimb46060305.
3
[Biological characteristics and clinical significance of stereotyped B-cell receptor in chronic lymphocytic leukemia].
Zhonghua Xue Ye Xue Za Zhi. 2024 Feb 14;45(2):197-202. doi: 10.3760/cma.j.cn121090-20230718-00012.
4
B cell receptor signaling and associated pathways in the pathogenesis of chronic lymphocytic leukemia.
Front Oncol. 2024 Feb 26;14:1339620. doi: 10.3389/fonc.2024.1339620. eCollection 2024.
5
Cost Effectiveness of Molecular Diagnostic Testing Algorithms for the Treatment Selection of Frontline Ibrutinib for Patients with Chronic Lymphocytic Leukemia in Australia.
Appl Health Econ Health Policy. 2024 Jan;22(1):107-122. doi: 10.1007/s40258-023-00826-4. Epub 2023 Aug 22.
6
Panel Sequencing for Clinically Oriented Variant Screening and Copy Number Detection in Chronic Lymphocytic Leukemia Patients.
Diagnostics (Basel). 2022 Apr 11;12(4):953. doi: 10.3390/diagnostics12040953.
7
Survival trends in chronic lymphocytic leukemia across treatment eras: US SEER database analysis (1985-2017).
Ann Hematol. 2021 Oct;100(10):2501-2512. doi: 10.1007/s00277-021-04600-1. Epub 2021 Jul 19.
8
IGHV mutational status of nodal marginal zone lymphoma by NGS reveals distinct pathogenic pathways with different prognostic implications.
Virchows Arch. 2020 Jul;477(1):143-150. doi: 10.1007/s00428-019-02712-8. Epub 2019 Dec 4.
9
status in chronic lymphocytic leukemia identify ethnic groups with an aggressive clinical course .
Haematologica. 2019 Oct;104(10):e493. doi: 10.3324/haematol.2019.219618.
本文引用的文献
1
Tailored approaches grounded on immunogenetic features for refined prognostication in chronic lymphocytic leukemia.
Haematologica. 2019 Feb;104(2):360-369. doi: 10.3324/haematol.2018.195032. Epub 2018 Sep 27.
2
iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL.
Blood. 2018 Jun 21;131(25):2745-2760. doi: 10.1182/blood-2017-09-806398. Epub 2018 Mar 14.
3
ERIC recommendations for TP53 mutation analysis in chronic lymphocytic leukemia-update on methodological approaches and results interpretation.
Leukemia. 2018 May;32(5):1070-1080. doi: 10.1038/s41375-017-0007-7. Epub 2018 Feb 2.
4
Single-agent ibrutinib in treatment-naïve and relapsed/refractory chronic lymphocytic leukemia: a 5-year experience.
Blood. 2018 Apr 26;131(17):1910-1919. doi: 10.1182/blood-2017-10-810044. Epub 2018 Feb 2.
5
Distinct homotypic B-cell receptor interactions shape the outcome of chronic lymphocytic leukaemia.
Nat Commun. 2017 Jun 9;8:15746. doi: 10.1038/ncomms15746.
6
Extended follow-up and impact of high-risk prognostic factors from the phase 3 RESONATE study in patients with previously treated CLL/SLL.
Leukemia. 2018 Jan;32(1):83-91. doi: 10.1038/leu.2017.175. Epub 2017 Jun 8.
7
Immunoglobulin gene sequence analysis in chronic lymphocytic leukemia: updated ERIC recommendations.
Leukemia. 2017 Jul;31(7):1477-1481. doi: 10.1038/leu.2017.125. Epub 2017 Apr 25.
8
Reliability of six prognostic models to predict time-to-first-treatment in patients with chronic lymphocytic leukaemia in early phase.
Am J Hematol. 2017 Jun;92(6):E91-E93. doi: 10.1002/ajh.24707. Epub 2017 Mar 24.
9
Antigen receptor stereotypy in chronic lymphocytic leukemia.
Leukemia. 2017 Feb;31(2):282-291. doi: 10.1038/leu.2016.322. Epub 2016 Nov 4.
10
Immunoglobulin gene rearrangements in Chinese and Italian patients with chronic lymphocytic leukemia.
Oncotarget. 2016 Apr 12;7(15):20520-31. doi: 10.18632/oncotarget.7819.
Zotero 插件